(VIANEWS) – PANORO ENERGY (PEN.OL), SHELL PLC (SHELL.AS), SPAREBANKEN VEST (SVEG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. PANORO ENERGY (PEN.OL)
1556.4% sales growth and 16.05% return on equity
Panoro Energy ASA, an independent exploration and production company, engages in the exploration, development, and production of oil and gas properties in Africa. It holds assets in the Equatorial Guinea, Gabon, Tunisia, and South Africa. The company was incorporated in 2009 and is based in London, the United Kingdom.
Earnings Per Share
As for profitability, PANORO ENERGY has a trailing twelve months EPS of kr3.16.
PE Ratio
PANORO ENERGY has a trailing twelve months price to earnings ratio of 7.92. Meaning, the purchaser of the share is investing kr7.92 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.05%.
Yearly Top and Bottom Value
PANORO ENERGY’s stock is valued at kr25.04 at 06:20 EST, way under its 52-week high of kr32.88 and above its 52-week low of kr24.08.
More news about PANORO ENERGY.
2. SHELL PLC (SHELL.AS)
16.8% sales growth and 10.31% return on equity
Shell plc operates as an energy and petrochemical company Europe, Asia, Oceania, Africa, the United States, and Rest of the Americas. The company operates through Integrated Gas, Upstream, Marketing, Chemicals and Products, and Renewables and Energy Solutions segments. It explores for and extracts crude oil, natural gas, and natural gas liquids; markets and transports oil and gas; produces gas-to-liquids fuels and other products; and operates upstream and midstream infrastructure necessary to deliver gas to market. The company also markets and trades natural gas, liquefied natural gas (LNG), crude oil, electricity, carbon-emission rights; and markets and sells LNG as a fuel for heavy-duty vehicles. In addition, it trades in and refines crude oil and other feed stocks, such as low-carbon fuels, lubricants, bitumen, sulphur, gasoline, diesel, aviation fuel, and marine fuel; produces and sells petrochemicals for industrial use; and manages oil sands activities. Further, the company produces base chemicals comprising ethylene, propylene, and aromatics, as well as intermediate chemicals, such as styrene monomer, propylene oxide, solvents, detergent alcohols, ethylene oxide, and ethylene glycol. Additionally, it generates electricity through wind and solar resources; produces and sells hydrogen; and provides electric vehicle charging services. The company was formerly known as Royal Dutch Shell plc and changed its name to Shell plc in January 2022. Shell plc was founded in 1907 and is headquartered in London, the United Kingdom.
Earnings Per Share
As for profitability, SHELL PLC has a trailing twelve months EPS of €2.64.
PE Ratio
SHELL PLC has a trailing twelve months price to earnings ratio of 11.21. Meaning, the purchaser of the share is investing €11.21 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.31%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SHELL PLC’s EBITDA is 13.08.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 12.6% and positive 47.9% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 15, 2024, the estimated forward annual dividend rate is 1.28 and the estimated forward annual dividend yield is 4.32%.
Yearly Top and Bottom Value
SHELL PLC’s stock is valued at €29.59 at 06:20 EST, below its 52-week high of €32.64 and way above its 52-week low of €24.66.
More news about SHELL PLC.
3. SPAREBANKEN VEST (SVEG.OL)
13.8% sales growth and 15.65% return on equity
Sparebanken Vest, a financial services company, provides banking and financing services in the counties of Vestland and Rogaland, Norway. The company operates through Corporate Market, Retail Market, Bulder Bank, Treasury, and Estate Agency Activities segments. It is also involved in home mortgage activities. The company was founded in 1823 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN VEST has a trailing twelve months EPS of kr11.5.
PE Ratio
SPAREBANKEN VEST has a trailing twelve months price to earnings ratio of 10.19. Meaning, the purchaser of the share is investing kr10.19 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.65%.
Volume
Today’s last reported volume for SPAREBANKEN VEST is 22846 which is 61.82% below its average volume of 59852.
Yearly Top and Bottom Value
SPAREBANKEN VEST’s stock is valued at kr117.20 at 06:20 EST, under its 52-week high of kr121.60 and way above its 52-week low of kr84.90.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 38.2% and 32%, respectively.
More news about SPAREBANKEN VEST.
4. SONAE (SON.LS)
10.5% sales growth and 9.35% return on equity
Sonae, SGPS, S.A. engages in retail, financial services, technology, shopping center, and telecommunications businesses. The company operates hypermarkets under the Continente brand; convenience supermarkets under the Continente Modelo and Continente Bom Dia brands; franchised supermarkets under the Meu Super brand; cafeteria under the Bagga brand; healthy food supermarkets and restaurants under the Go Natural brand; book shops and stationery under the Make Notes and Note! brands; health, well-being, and eye care centers under the Well´s brand; and dental and aesthetic medicine clinics under the Dr. Well's brand, as well as provides dog and cat products and services under the ZU brand. It also offers clothing, footwear, and accessories under the MO brand; baby and children clothing, footwear, and accessories, as well as childcare products under the Zippy and Losan brands; and jeans, clothing, and accessories under the Salsa brand. In addition, the company sells consumer electronics and entertainment products under the Worten brand; and mobile telecommunications products under the Worten Mobile brand, as well as develops real estate properties. Further, it offers payments, cards, personal loans, and insurance under the Universo brand; financing online purchases under the Universo Flex brand; and meal vouchers, gifting, and rewarding under the Da cards brand, as well as operates sports retail stores under JD, Sprinter, and Size? brand names. Additionally, the company provides telecommunication services to residential, personal, corporate, and wholesale markets; and investment management activities. It operates in Portugal, Spain, France, the United Kingdom, Germany, Italy, Romania, Brazil, Mexico, the Netherlands, and internationally. Sonae, SGPS, S.A. was founded in 1959 and is headquartered in Maia, Portugal. Sonae, SGPS, S.A. operates as a subsidiary of Efanor Investimentos SGPS, SA.
Earnings Per Share
As for profitability, SONAE has a trailing twelve months EPS of €0.11.
PE Ratio
SONAE has a trailing twelve months price to earnings ratio of 8.09. Meaning, the purchaser of the share is investing €8.09 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.35%.
More news about SONAE.
5. BOUVET (BOUV.OL)
9.7% sales growth and 60.9% return on equity
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. Bouvet ASA was founded in 1995 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.15.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 19.49. Meaning, the purchaser of the share is investing kr19.49 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 3.22B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 24, 2023, the estimated forward annual dividend rate is 2.5 and the estimated forward annual dividend yield is 4.08%.
Yearly Top and Bottom Value
BOUVET’s stock is valued at kr61.40 at 06:20 EST, way below its 52-week high of kr70.00 and way higher than its 52-week low of kr52.00.
Moving Average
BOUVET’s value is under its 50-day moving average of kr63.78 and below its 200-day moving average of kr62.05.
More news about BOUVET.
6. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 23.5. Meaning, the purchaser of the share is investing kr23.5 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Volume
Today’s last reported volume for VISTIN PHARMA is 8283 which is 36.23% below its average volume of 12990.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 23, 2024, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 3.11%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 438.54M for the twelve trailing months.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the present quarter and 6.6% for the next.
More news about VISTIN PHARMA.
